Novel options for the treatment of castration-resistant prostate cancer.
about
Axitinib and crizotinib combination therapy inhibits bone loss in a mouse model of castration resistant prostate cancer.Phase 1/2 study of orteronel (TAK-700), an investigational 17,20-lyase inhibitor, with docetaxel-prednisone in metastatic castration-resistant prostate cancer.Targeted α-particle therapy of bone metastases in prostate cancerChemotherapeutic inhibitors in the treatment of prostate cancer.Development of enzalutamide for metastatic castration-resistant prostate cancer.The Effect of Targeted Therapy for Genitourinary Malignancies on Sexual Function and Fertility.Is there an anti-androgen withdrawal syndrome for enzalutamide?Enzalutamide in European and North American men participating in the AFFIRM trial.Absorption, Distribution, and Excretion of the Investigational Agent Orteronel (TAK-700) in Healthy Male Subjects: A Phase 1, Open-Label, Single-Dose Study.
P2860
Q34309227-32A66563-C37E-4300-BDE0-0E616B1647ADQ35328550-0A4EBF6E-FC72-42D6-82FB-76F5B7C59462Q37417656-B308F4E2-02EA-40DD-9B6A-0130CB0CE628Q38155239-E3554D70-266D-4D90-9ED2-BCADD2457703Q38589130-3B2793B7-1A8E-4D38-AF1C-E37F39207BE8Q38677185-C34B0B87-91F3-4DF4-9930-27267D335DFCQ39217798-847FD933-F31B-4DC6-B2D2-142E29A8288FQ43125202-3117C19D-AAEA-453B-B172-B5D2352BB94CQ53103001-5542259E-C47C-4B11-9BDD-F6520B2B77FE
P2860
Novel options for the treatment of castration-resistant prostate cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Novel options for the treatment of castration-resistant prostate cancer.
@en
Novel options for the treatment of castration-resistant prostate cancer.
@nl
type
label
Novel options for the treatment of castration-resistant prostate cancer.
@en
Novel options for the treatment of castration-resistant prostate cancer.
@nl
prefLabel
Novel options for the treatment of castration-resistant prostate cancer.
@en
Novel options for the treatment of castration-resistant prostate cancer.
@nl
P2093
P2860
P1476
Novel options for the treatment of castration-resistant prostate cancer.
@en
P2093
Axel S Merseburger
Carsten Kempkensteffen
Carsten-H Ohlmann
David Schilling
Henrik Suttmann
Lutz Trojan
Michael J Mathers
Patrick J Bastian
Stefan Corvin
P2860
P2888
P304
P356
10.1007/S00345-011-0796-7
P577
2011-11-20T00:00:00Z